FTO and cardiac hypertrophy: Erkens et al. (52) found that SERCA2a was downregulated in Nrf2 KO mice, associated with LV dysfunction and cardiac hypertrophy, while FTO demethylates SERCA2a, suggesting that FTO is a key factor in Nrf2-associated cardiac hypertrophy.